Omnicare Announces Conversion Rate Adjustments for Convertible Notes
(Thomson Reuters ONE) -
CINCINNATI, August 18, 2015 - Omnicare, Inc. (the "Company") announced today an
adjustment to the conversion rate of its (i) 3.75% Convertible Senior
Subordinated Notes due 2025 (the "2025 Notes"), (ii) 3.50% Convertible Senior
Subordinated Notes due 2044 (the "2044 Notes"), (iii) 3.25% Convertible Senior
Debentures due 2035 (the "Debentures") and (iv) 3.25% Convertible Senior
Exchange Debentures due 2035 (the "Exchange Debentures" and, together with the
Debentures, the "2035 Debentures"). Effective August 18, 2015, the adjusted
conversion rate for (i) the 2025 Notes is 37.7191 shares of common stock per
$1,000 principal amount, (ii) the 2044 Notes is 14.3863 shares of common stock
per $1,000 principal amount, provided, that, the conversion rate with respect to
any conversions "in connection with" the Non-Stock Change of Control, as defined
in the applicable indenture, is 15.2307 and (iii) the 2035 Debentures is
13.0483 shares of common stock per $1,000 principal amount; provided, that, the
conversion rate with respect to any conversions "in connection with" the Non-
Stock Change of Control, as defined in the applicable indenture, is 13.1278.
The conversion rates were initially adjusted in connection with the Company's
regular quarterly dividend payments. The further adjustments to the conversion
rates "in connection with" the Non-Stock Change of Control, are in connection
with the consummation of the transactions contemplated by the Agreement and Plan
of Merger, dated as of May 20, 2015, by and among the Company, CVS Pharmacy,
Inc., a Rhode Island corporation ("CVS Pharmacy"), and Tree Merger Sub, Inc.
("Merger Sub"), a Delaware corporation and wholly owned subsidiary of CVS
Pharmacy, pursuant to which Merger Sub merged with and into the Company, with
the Company continuing as the surviving company and a wholly owned subsidiary of
CVS Pharmacy.
About Omnicare
Omnicare, Inc., a wholly owned subsidiary of CVS Health Corporation, provides
comprehensive pharmaceutical services to patients and providers across the
United States. As the market-leader in professional pharmacy, related
consulting and data management services for skilled nursing, assisted living and
other chronic care institutions, Omnicare leverages its unparalleled clinical
insight into the geriatric market along with some of the industry's most
innovative technological capabilities to the benefit of its long-term care
customers. Omnicare also provides specialty pharmacy and key commercialization
services for the bio-pharmaceutical industry through its Specialty Care Group.
For more information, visit www.omnicare.com.
# # #
Contact:
Patrick C. Lee
(513) 719-1507
patrick.lee(at)omnicare.com
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Omnicare via GlobeNewswire
[HUG#1946363]
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
" alt="Equitas Resources Corp. Announces $1,800,000 Non-Brokered Private Placement
Datum: 18.08.2015 - 23:11 Uhr
Sprache: Deutsch
News-ID 414574
Anzahl Zeichen: 3675
contact information:
Town:
Covington, KY
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 134 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Omnicare Announces Conversion Rate Adjustments for Convertible Notes"
steht unter der journalistisch-redaktionellen Verantwortung von
Omnicare (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
